AZoLifeSciences on MSN7h
RNA Splicing Errors May Hold the Key to Beating Gliomas Using Immunotherapy
Identifying splicing-related neoantigens in gliomas opens new avenues for immunotherapy, enhancing treatment strategies for ...
manilatimes7h
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company” or "Plus Therapeutics”), a clinical-stage pharmaceutical company ...
Cure Today22h
FDA Accepts NDA For Dordaviprone in H3 K27M-Mutant Diffuse Glioma
A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...